Relationship between erythropoietin and nitric oxide in the contraction of rat renal arcuate arteries and human umbilical vein endothelial cells

Clinical Science

Volumn 97, Issue 4, 1999, Pages 413-419

  Wu, Xiao Chun ^a   Johns, Edward J ^a   Richards, Nicholas T ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Erythropoietin; Human umbilical vein endothelial cells; Nitric oxide; Renal arcuate arteries; Wistar rats

Indexed keywords

ACETYLCHOLINE; DOPAMINE; ERYTHROPOIETIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; RECOMBINANT ERYTHROPOIETIN;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIVISION; CULTURE TECHNIQUES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ERYTHROPOIETIN, RECOMBINANT; HUMANS; MALE; NITRIC OXIDE; NOREPINEPHRINE; RATS; RATS, WISTAR; RENAL ARTERY; UMBILICAL VEINS; VASOCONSTRICTION;

EID: 0032827167     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS19990055     Document Type: Article

References (19)

1. 1 Yoshioka, E., Thompson, J., Miller, M. J. S. and Fisher, J. W. (1997) Inducible nitric oxide synthase expression and erythropoietin production in human hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 232, 702-706
2. 2 Tsukahara, H., Hiraoka, M., Hori, C. et al. (1997) Chronic erytbropoietin treatment enhances endogenous nitric oxide production in rats. Scand. J. Clin. Lab. Invest. 57, 487-493
3. 3 Vaupel, D. B. Kimes, A. S. and London, E. D. (1997) Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur. J. Pharmacol. 324, 11-20
4. 4 Vaziri, N. D., Zhou, X. J., Smith, J., Oveisi, K., Baldwin, K. and Purdy, R. E. (1995) In vivo and in vitro pressor effects of erythropoietin in rats. Am. J. Physiol. 269, F838-F845
5. 5 Rudko, I. A., Balashova, T. S., Kuatiev, A. A. and Ermolenko, V. M. (1994) The action of recombinant human erythropoietin (Rhc) on platelet and red-cell function in chronic-renal-failure patients on hemodialysis. Terapevticheskii Arkhiv. 66, 57-60
6. 6 Buemi, M., Denuzzo, G., Allegra, A. et al. (1995) Recombinant human erythropoietin inhibits the cutaneous vasodilatation induced by acetylcholine. Int. J. Microcirc. Clin. Exp. 15, 283-286
7. 7 Vaziri, N. D, Zhou, X. J., Naqvi, F. et al. (1996) Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure. Am. J. Physiol. 271, E113-E122
8. 8 Mulvany, M. J. and Halpern, W. (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41, 19-26
9. 9 Jaffe, E. A., Nachman, R. L., Becker, C. J. and Minick, C. R. (1973) Culture of human endothelial cells derived from umbilical veins. Identification of morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756
10. 10 Menon, N. K., Pataricza, J., Binder, T. and Bing, R. J. (1991) Reduction of biological effluents in purge and trap microreaction vessels and detection of endothelium-derived nitric oxide (Edno) by chemiluminescence. J. Mol. Cell. Cardiol. 23, 389-393
11. 11 Wu, X. C., Richards, N. T., Michael, J. and Johns, E. (1994) Relative roles of nitric oxide and cyclooxygenase and lipoxygenase products of arachidonic acid in the contractile responses of rat renal arcuate arteries. Br. J. Pharmacol. 112, 369-376
12. 12 Amenta, F. (1997) Light microscope autoradiography of peripheral dopamine receptor subtypes. Clin. Exp. Hypertens. 19, 27-41
13. 13 Van der Graaf, P. H., Saxena, P. R., Shankley, N. P. and Black, J. W. (1995) Exposure and characterization of the action of noradrenaline at dopamine receptors mediating endothelium-independent relaxation of rat isolated small mesenteric arteries. Br. J. Pharmacol. 116, 3237-3242
14. 14 Carlini, R. G., Gupta, A., Liapis, H. and Rothstein, M. (1995) Endothelin-1 release by erythropoietin involves calcium signaling in endothelial cells. J. Cardiovasc. Pharmacol. 26, 889-892
15. 15 Bode-Böger, S. M., Boger, R. H., Kuhn, M., Radermacher, J. and Frolich, J. C. (1992) Endothelin release and shift in prostaglandin balance are involved in the modulation of vascular tone by recombinant erythropoietin. J. Cardiovasc. Pharmacol. 20, 25-28
16. 16 Moreland, S., McMullen, D., Abboaoffei, B. and Seymour, A. (1994) Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature. Br. J. Pharmacol. 112, 704-708
17. 17 Jacobson, L. D., Goldwsser, E., Fried, W. and Plzak, L. (1957) Role of the kidney in erythropoiesis. Nature (London) 179, 633-634
18. 18 Goldberg, M., Dunning, S. and Bunn, F. (1988) Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242, 1412-1415
19. 19 Dalloz, F., Maupoil, V., Lecour, S., Briot, F. and Rochette, L. (1997) In vitro studies of interactions of NO donor drugs with superoxide and hydroxyl radicals. Mol. Cell. Biochem. 177, 193-200